You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Taxotere

Showing 51 - 75 of 895
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
May 5, 2022

NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Apr 15, 2023

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Tumors, Breast Trial in France, Ireland, United States (lapatinib, docetaxel, trastuzumab)

Terminated
  • Neoplasms, Breast
  • lapatinib, docetaxel, trastuzumab
  • Nashville, Tennessee
  • +4 more
Jun 30, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Seattle

Terminated
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 3, 2021

Head and Neck Squamous Cell Carcinoma Trial in Tours (Docetaxel, Cisplatin, Fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tours, France
    Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan
Mar 10, 2022

Laryngeal Cancer Trial in Ann Arbor (AT-101, Docetaxel, Cisplatin)

Completed
  • Laryngeal Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 17, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Frankfurt, Germany
  • +1 more
Apr 14, 2022

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Breast Cancer Trial (Gemcitabine, Epirubicin, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • (no location specified)
Oct 4, 2021

Triple Negative Breast Tumors Trial in Saint Louis (Docetaxel, Carboplatin, FDG-PET/MR)

Terminated
  • Triple Negative Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 6, 2022

Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma Trial in Scottsdale, Jacksonville, Rochester (procedure,

Not yet recruiting
  • Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
  • Biospecimen Collection
  • +11 more
  • Scottsdale, Arizona
  • +2 more
Sep 12, 2022

Breast Cancer Trial in Brazil (Docetaxel or Paclitaxel, Cyclophosphamide + Doxorrubicin)

Recruiting
  • Breast Cancer
  • Docetaxel or Paclitaxel
  • Cyclophosphamide + Doxorrubicin
  • Goiânia, Goiás, Brazil
  • +9 more
Jan 5, 2023

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021

Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Active, not recruiting
  • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 4, 2022

Neutropenia, Breast Cancer Trial in United States (Eflapegrastim, Docetaxel, Cyclophosphamide)

Recruiting
  • Neutropenia
  • Breast Cancer
  • Eflapegrastim
  • +2 more
  • Tucson, Arizona
  • +7 more
Nov 4, 2022

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +9 more
  • Atezolizumab
  • +12 more
  • (no location specified)
Apr 26, 2023

NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)

Terminated
  • Non-small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Apr 4, 2022

Adenocarcinoma Trial in Denmark (Docetaxel, Oxaliplatin, Capecitabine)

Completed
  • Adenocarcinoma
  • Aalborg, Denmark
  • +3 more
Oct 29, 2020